Cite
Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1).
MLA
Smith, Ellen M.Lavoie, et al. “Patient-Targeted Education (EPRO-E) to Increase EPRO Intent within an Alliance Clinical Trial (A221805-SI1).” JNCI Cancer Spectrum, vol. 8, no. 1, Feb. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1093/jncics/pkae002.
APA
Smith, E. M. L., Cho, Y., Hillman, S., Scott, M. R., Harlos, E., Wills, R., Loprinzi, C., Wilson, C. M., & Zahrieh, D. (2024). Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1). JNCI Cancer Spectrum, 8(1), 1–9. https://doi.org/10.1093/jncics/pkae002
Chicago
Smith, Ellen M Lavoie, Youmin Cho, Shauna Hillman, Mary R Scott, Elizabeth Harlos, Rachel Wills, Charles Loprinzi, Christina M Wilson, and David Zahrieh. 2024. “Patient-Targeted Education (EPRO-E) to Increase EPRO Intent within an Alliance Clinical Trial (A221805-SI1).” JNCI Cancer Spectrum 8 (1): 1–9. doi:10.1093/jncics/pkae002.